Function | Drug | Dosage form | Treatment |
---|---|---|---|
Promote the release of the lysosomes of mucus-secreting cells | Bromhexine | Injection | Chronic bronchitis, asthma and other causes of phlegm is not easy to cough |
Promote the release of the lysosomes of mucus-secreting cells | Ambroxol | Inhalation & Injection | Chronic bronchitis, asthma and other causes of phlegm is not easy to cough |
Adrenalin β2 receptor agonist | Salbutamol sulfate | Inhalation & Injection | Asthma, asthmatic bronchitis, bronchospasm in an emphysema patient |
Adrenalin β2 receptor agonist | Terbutaline sulfate | Inhalation & Injection | Bronchial asthma, chronic bronchitis, asthmatic bronchitis, emphysema and other airway obstructive diseases caused by dyspnea |
Long-acting adrenalin β2 receptor agonist | Formoterolfumarate | Inhalation | Bronchial asthma, chronic bronchitis, asthmatic bronchitis, emphysema and other airway obstructive diseases caused by dyspnea |
Cholinergic receptor (M receptor) antagonist | Ipratropium bromide | Inhalation | Chronic obstructive pulmonary disease (COPD) and asthma |
Adrenocorticosteroids | Budesonide | Inhalation | Chronic obstructive pulmonary disease (COPD) and asthma |
Phosphodiesterase (PDE) inhibitors | Doxofylline | Injection &Suspension | Bronchial asthma, asthmatic chronic bronchitis and other bronchospasm caused by dyspnea |
Diversified dosage forms ofparenteral administration products
★ Liposome, microsphere preparation
★ Parenteral emulsion
★ Special line preparation
★ Lyophilized preparation
★ Hormone injection
★ Large-volume injection
Diversified dosage forms of oral administration products
★ Regular release tablets
★ Sustained and controlled release tablets
★ Compound preparation
★ Capsules
★ Single dose suspension
★ Multi-dose suspension
Diversified dosage forms of other administration products
★ Inhalation preparation
★ Single dose eye drops
★ Dialysis solution
★ Irrigation solution
Anesthesia, surgery, contrast agent
Function | Drug | Dosage form | Treatment |
---|---|---|---|
Local anesthesia - caine class | Ropivacaine hydrochloride lidocaine Bupivacaine Levobupivacaine | Small-volume injection Liposome | Surgical anesthesia, acute pain control, local infiltration anesthesia |
Alpha 2- adrenergic receptor agonists | Dexmedetomidine | Small-volume injection | Sedation during tracheal intubation and mechanical ventilation in surgical patients undergoing general anesthesia |
Adrenergic receptor agonists | Norepinephrine Phenylephrine Isoprenaline | Small-volume injection | Complete atrioventricular block and cardiac arrest |
Neuromuscular blockers | Cis-atracurium Rocuronium bromide | Small-volume injection | Adjuncts to general anesthesia or sedation in the intensive care unit (ICU) |
Selective relaxation binder | Sulgenoglucose | Injection | Antagonizes neuromuscular block induced by rocuronium or vecuronium |
Contrast agents | Disodium Gadolinium serate Gadolinium testamine Gadobutrol Indocyanine green | Small-volume injection Lyophilized powder | Detect focal liver lesions Detect cerebral and spinal lesions Magnetic resonance imaging of brain and spinal cord Detect liver function and effective blood flow |
Cardiovascular disease
Function | Drug | Dosage form | Treatment |
---|---|---|---|
Antihypertensive | Valsartan amlodipine Levamlodipine Urapidil Felodipine Nifedipine | Tablets Sustained release tablet | Essential hypertension Hypertension, angina pectoris Severe and extremely severe hypertension and refractory hypertension Hypertension, stable anginapectoris Hypertension, angina pectoris |
Hypolipidemic | Compound preparation of rosuvastatin calcium and pivastatin calcium | Tablets | Hypercholesterolemia |
Others | Argatroban Tirofiban Butyl phthalide | Small volume injection | To improve the symptoms of limb ulcers, resting pain and cold sensation in patients with chronic arterial occlusion Acute coronary syndrome, prevention of early myocardial infarction Improvement of neurological deficits in patients with acute ischemic stroke |
Diabetes and nephropathy
Function | Drug | Dosage form | Treatment |
---|---|---|---|
Antidiabetics | Gliclazide, Dapagliflozin, Trelagliptin, Alogliptin, Compound hypoglycemic drugs | Tablets | Diabetes |
Diabetic complications | Epalrestat, Lipoic acid, Mecobalamine, Pentotheobromine, Dapagliflozin | Small volume injection, Compressed tablets, Sustained release tablet | Diabetes Neuropathies, Diabetic Nephropathy |
Field of kidney disease | Hemofiltration base replacement solution, Peritoneal dialysis solution, Bicarbonate dialysate | Dialysate | Kidney disease universal dialysis |
Field of kidney disease | Cinacalcet | Tablets | Secondary hyperparathyroidism in chronic kidney disease (CKD) patients undergoing maintenance dialysis |
Neuropsychiatric diseases
Focus on elderly Parkinson's disease
Function | Drug | Dosage form | Treatment |
---|---|---|---|
GABA receptor | Stiripentol | Suspension | Anticonvulsant drugs for epilepsy, Dravet syndrome |
Voltage-gated Na+ channels selectively enhance the slow inactivation of voltage-gated sodium channels | Lacosamide | Tablets | Adjuvant treatment of partial seizures with or without secondary full-blown seizures |
Dopamine and serotonin receptor antagonists | Blonanserin | Tablets | Schizophrenia |
Dopamine and serotonin receptor antagonists | Lurasidone | Tablets | Schizophrenia and bipolar depression |
Levodopa + benserazide compound preparation | Levodopa and Benserazide | Tablets | Parkinson's disease, symptomatic Parkinson's syndrome |
Catechol-O-methyltransferase (COMT) inhibitor | Entacarbon and Compound | Tablets | Adjunctive use of levodopa/benserazide or levodopa/carbidopa |
Monoamine oxidase type B(MAO-B) inhibitors | Safinamide | Tablets | Adjunctive therapy of levodopa/carbidopa in Parkinson's disease |
Monoamine oxidase type B(MAO-B) inhibitors | Rasagiline | Tablets | Monotherapy for primary Parkinson's disease, combined therapy with end-dose fluctuations |
5-HT1A. 5-HT1B agonist, 5-HT3', 5HT1D, 5-HT7 receptor antagonist | Vortioxetine | Tablets | Major depression |
Antibiotic treatment
Focus on dry suspension for children
Function | Drug | Dosage form | Treatment |
---|---|---|---|
Macrolides | Azithromycin | Tablets, lyophilized powder for injection, suspension | Mild to moderate infection |
Cephalosporin | Cefdinir Cefaclor Cefuroxime Axetil | Capsules Suspension Suspension | Bacterial infection, sensitive bacterial infection |
Floxacin | Moxifloxacin Delafloxacin | Infusion, tablets, eye drops Tablets, lyophilized powder for injection | Sensitive bacterial infection, Acute bacterial skin and skin structure infection |
Oxazolidones | Linezolid Tedizolid | Infusion, suspension, Tablets, lyophilized powder for injection | Sensitive bacterial infection, Acute bacterial skin and skin structure infection |
Econazole | Fluconazole Voriconazole | Infusion, tablets, Suspension | Fungal infection |
Nidazole | Metronidazole Tinidazole Ornidazole Levornidazole | Infusion, tablets, Tablets Tablets, small-volume injection Infusion | Anaerobe infection |
Polypeptide drugs
Item name | Dosage form | Specifications | Indications |
---|---|---|---|
Carbetocin | API + injection | 1ml:100μg | It is used after selective epidural or lumbar anesthesia caesarean section to prevent uterine weakness and postpartum bleeding |
Pitocin | API + injection | 5IU/ml,10IU/ml | It is used for induction of labor, oxytocin, postpartum and abortion due to uterine weakness or poor contraction of uterine bleeding |
Terisopressin acetate | API + injection | 8.5ml:1mg,1mg | It is used for the treatment of liver cirrhosis complications (esophagogastricvariceal hemorrhage, hepatorenal syndrome, ascites) and other bleeding treatments |
Octreotide acetate | API + injection | 1ml:0.1mg;1ml:0.2mg | Emergency treatment of esophageal variceal hemorrhage caused by cirrhosis; Relief of symptoms and signs associated with gastrointestinal and pancreatic endocrine tumors |
Cetrorelixacetate | API + Lyophilized preparation | 0.25mg | It is mainly used in assisted fertility technology to prevent ovulation in advance for patients with controlled ovarian stimulation. |
Ganiric acetate | API + injection | 0.5ml:0.25mg | It is used in women undergoing an assisted reproductive technology (ART) controlled ovarian stimulation (COS) programme |
Atosiban acetate | API + injection | 0.9ml:735mg,5ml:37.5mg | Gynecological fetus protection |
Calcitriol | API + injection | 1ml:1μg | Hypocalcemia in chronic renal dialysis patients |
Carprostaminobuttriol | API + injection | 1ml:250μg | Suitable for pregnancy of 13 weeks to 20 weeks of abortion |
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Copyright © 2021 SJZ No.4 Pharmaceutical 冀ICP备05007979号-1